NCT06761885

Brief Summary

To check if maternal serum (hcg \_h ) in second and third trimester in pregnant woman with placenta previa can predict placenta accreta at delivery or predict adverse maternal and neonatal outcome

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

January 7, 2025

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 31, 2024

Last Update Submit

December 31, 2024

Conditions

Placenta Accreta / Percreta

Outcome Measures

Primary Outcomes (1)

  • Prediction of degree of placenta adherence by (hcg_h) and correlation intraoperative finding

    Prediction of degree of placenta adherence by (hcg\_h) and correlation intraoperative finding

    12months

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

* pregnant woman * At least previous one CS * Gestational age at second and third trimester * Age (18:45) years

You may qualify if:

  • pregnant woman
  • At least previous one CS
  • Gestational age at second and third trimester
  • Age (18:45) years

You may not qualify if:

  • proven fetal aneuploidy in current pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Central Study Contacts

Esraa Mohammed, Resident

CONTACT

01220940533Esraa.16265998@med.aun.edu.eg

Ahmed Ahmed, Prof.Dr

CONTACT

01012588888Anasr@aun.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
74 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of women's health Assiut University hospital

Study Record Dates

First Submitted

December 31, 2024

First Posted

January 7, 2025

Study Start

January 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

January 7, 2025

Record last verified: 2024-12